Janux Therapeutics (JANX) Other Gross PP&E Adjustments (2020 - 2025)
Historic Other Gross PP&E Adjustments for Janux Therapeutics (JANX) over the last 6 years, with Q3 2025 value amounting to -$8.1 million.
- Janux Therapeutics' Other Gross PP&E Adjustments rose 1783.18% to -$8.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.1 million, marking a year-over-year increase of 1783.18%. This contributed to the annual value of -$13.2 million for FY2024, which is 1168.43% up from last year.
- Latest data reveals that Janux Therapeutics reported Other Gross PP&E Adjustments of -$8.1 million as of Q3 2025, which was up 1783.18% from -$7.8 million recorded in Q2 2025.
- In the past 5 years, Janux Therapeutics' Other Gross PP&E Adjustments registered a high of $2.7 million during Q1 2022, and its lowest value of -$18.9 million during Q2 2022.
- For the 5-year period, Janux Therapeutics' Other Gross PP&E Adjustments averaged around -$9.4 million, with its median value being -$10.4 million (2024).
- In the last 5 years, Janux Therapeutics' Other Gross PP&E Adjustments tumbled by 2089294.12% in 2022 and then skyrocketed by 3494.69% in 2023.
- Quarter analysis of 5 years shows Janux Therapeutics' Other Gross PP&E Adjustments stood at $85000.0 in 2021, then plummeted by 20892.94% to -$17.7 million in 2022, then rose by 15.55% to -$14.9 million in 2023, then increased by 11.68% to -$13.2 million in 2024, then skyrocketed by 38.48% to -$8.1 million in 2025.
- Its last three reported values are -$8.1 million in Q3 2025, -$7.8 million for Q2 2025, and -$8.5 million during Q1 2025.